The stock is currently trading at an EV/EBITDA of 4.8 times, according to analysts at the company.
This is lower than the 20-year average of 7.8. Compared to similar US companies, the discount is greater than 60%, and compared to non-American companies, it is between 20% and 30%. Euroxx suggests that the equities have been re-rated significantly higher in 2023, but there is still significant upside ahead due to hidden value from US operations, strong structural recovery from the Greek market, solid growth and margins from SE European operations, and balance sheet leverage. The estimated net debt/EBITDA for 2023 is 1.4x.
